New Approaches for Brittle Bones (Osteogenesis Imperfecta)
Targeting TGFb In Osteogenesis Imperfecta
This research explores new ways to treat brittle bones in people with Osteogenesis Imperfecta by looking at a protein called TGFβ.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11121028 on NIH RePORTER |
What this research studies
Osteogenesis Imperfecta (OI) causes bones to break easily, and current treatments like bisphosphonates don't always work well for everyone, especially adults or those with milder forms. Researchers have found that a protein called TGFβ might be too active in OI, contributing to bone problems and possibly making other treatments less effective. This project will investigate how TGFβ affects bone health in OI and whether blocking its activity could lead to stronger bones. The goal is to develop better treatment options for people living with this condition.
Who could benefit from this research
Good fit: The research focuses on Osteogenesis Imperfecta, including both children and adults, particularly those with severe OI or those who haven't fully benefited from existing treatments.
Not a fit: Patients without Osteogenesis Imperfecta would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this could lead to new, more effective treatments for Osteogenesis Imperfecta, especially for those who don't respond well to current therapies.
How similar studies have performed: Previous studies in mice have shown that blocking TGFβ improved bone health in models of Osteogenesis Imperfecta, suggesting this approach has promise.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Bae, Yangjin — Baylor College of Medicine
- Study coordinator: Bae, Yangjin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.